Andrea Volk, MD
Dermatopathology · Atlanta, GANPI 1659306793
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Merz North America, Inc. at 58.4% of the total. Reporting peaked in 2022 at $165 and has fallen 87.7% since, to $20 in 2025.
Across 14 payments — averaging $35.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$290
- Revance Therapeutics, Inc.$66
- Novo Nordisk$62
- Incyte Corporation$44
- Sun Pharmaceutical Industries Inc.$22
- Galderma Laboratories, L.p.$13
What the payments were for
- Food & beverage$497100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 5 | $290 |
| Revance Therapeutics, Inc. | 2 | $66 |
| Novo Nordisk | 3 | $62 |
| Incyte Corporation | 2 | $44 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $13 |
How this compares
$497 in reported general payments places this provider in the 75th percentile of 25 dermatopathology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatopathology in Atlanta
- Gautham VellaichamyAtlanta$2K
- Melinda MohrAtlanta$380
- Julie BarberAtlanta$124
- Emily HenkelAtlanta$103
- Stephen TempletonAtlanta$90
- Amrit SinghAtlanta$41
- Christine LeeAtlanta$23
- Marian FinanAtlanta$15
- Narayan NaikAtlanta$15
- Kathleen SmithDecatur$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.